Related Experiment Video
Updated: Aug 23, 2026

Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
Published on: February 10, 2023
Preferential coronary arterial drug delivery
J H Anderson1, C Gianturco, S Wallace
1Department of Radiology and Radiological Sciences, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA.
Abstract:
A transcatheter technique for administering drugs preferentially to the canine left coronary circulation is described. The method involves pulsed, diastolic, small-volume (0.2 ml) injections through a specially designed aortic cusp catheter. In order to evaluate preferential delivery to the coronary circulation, papaverine was administered using this technique and compared to intravenous delivery. Left circumflex and carotid arterial blood flow, as well as systemic arterial pressure, were simultaneously measured. In eight of ten animals studied, diastolic aortic cusp administration of the drug for periods of up to 30 minutes increased circumflex flow an average of 136%, increased carotid arterial flow 22%, and decreased systemic arterial pressure 18%. Intravenous delivery increased circumflex flow an average of 34%, increased carotid flow 41%, and decreased systemic arterial pressure 13%. The technique has immediate research and potential clinical application as a means of preferentially delivering diagnostic or therapeutic agents, such as thrombolytics, to the coronary circulation.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Drug Delivery: Enteral Route
Drugs in...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Modified-Release Drug Delivery Systems: Site-Targeted
Coronary Artery Disease IV: Preventive Measures
